BBIO 8-K 2026-06-26

BridgeBio Pharma, Inc. (BBIO) 8-K dated 2026-06-26 — accession 0001140361-26-026506. This URL is the filing, not the BBIO hub.

BridgeBio Pharma, Inc. (BBIO) is a biotechnology company listed on US.

BridgeBio Pharma, Inc. filed a 8-K on 2026-06-26. Accession 0001140361-26-026506.

Cached items: 5.02, 5.07, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BBIO revenue for 2026-06-30 was $438.2M. Net income was -$322.4M. BBIO currently screens at market cap $13.24B.

Not investment advice. The BBIO SEC hub lists recent forms. The stock page is the research view.